Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effect

Journal of the Neurological Sciences

Volumn 339, Issue 1-2, 2014, Pages 207-209

  Ishibashi, Kenji ^a   Oda, Keiichi ^a   Ishiwata, Kiichi ^a   Ishii, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Aging; Dopamine transporter; Parkinson's disease; Positron emission tomography; Striatum

Indexed keywords

DOPAMINE TRANSPORTER;

AGE; AGED; AGING; ARTICLE; CASE REPORT; CAUDATE NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DETERIORATION; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; ADULT; MALE; METABOLISM; MIDDLE AGED; PROCEDURES; SCINTISCANNING;

ADULT; AGED; AGING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84898057061     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.01.015     Document Type: Article

References (16)

1. H.C. Cheng, C.M. Ulane, and R.E. Burke Clinical progression in Parkinson disease and the neurobiology of axons Ann Neurol 67 6 Jun 2010 715 725
2. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 Pt 5 Oct 1991 2283 2301
3. C.D. Marsden Parkinson's disease Lancet 335 8695 Apr 21 1990 948 952
4. R. Nandhagopal, L. Kuramoto, M. Schulzer, E. Mak, J. Cragg, and J. McKenzie et al. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease Brain 134 Pt 11 Nov 2011 3290 3298
5. K. Ishibashi, K. Ishii, K. Oda, K. Kawasaki, H. Mizusawa, and K. Ishiwata Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum Synapse 63 4 Apr 2009 282 290
6. 11C]CFT binding to the striatal dopamine transporters in the Fischer 344 rats: a PET study Ann Nucl Med 17 3 May 2003 249 253
7. D. Martinez, M. Slifstein, A. Broft, O. Mawlawi, D.R. Hwang, and Y. Huang et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum J Cereb Blood Flow Metab 23 3 Mar 2003 285 300
8. 123I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET Eur J Nucl Med Mol Imaging 37 1 Jan 2010 3 11
9. O. Mawlawi, D. Martinez, M. Slifstein, A. Broft, R. Chatterjee, and D.R. Hwang et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum J Cereb Blood Flow Metab 21 9 Sep 2001 1034 1057
10. K. Basar, T. Sesia, H. Groenewegen, H.W. Steinbusch, V. Visser-Vandewalle, and Y. Temel Nucleus accumbens and impulsivity Prog Neurobiol 92 4 Dec 2010 533 557
11. P. Damier, E.C. Hirsch, Y. Agid, and A.M. Graybiel The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease Brain 122 Pt 8 Aug 1999 1437 1448
12. M. Maingay, M. Romero-Ramos, M. Carta, and D. Kirik Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression Neurobiol Dis 23 3 Sep 2006 522 532
13. 18F]fluoro-l-dopa uptake in early Parkinson's disease: a two-year follow-up study Mov Disord 21 7 Jul 2006 958 963
14. 18F-dopa PET study Neuroimage 56 3 Jun 1 2011 1463 1468
15. R. Nandhagopal, L. Kuramoto, M. Schulzer, E. Mak, J. Cragg, and C.S. Lee et al. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study Brain 132 Pt 11 Nov 2009 2970 2979
16. S.J. Lewis, T. Foltynie, A.D. Blackwell, T.W. Robbins, A.M. Owen, and R.A. Barker Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach J Neurol Neurosurg Psychiatry 76 3 Mar 2005 343 348